Autoimmunity: Lasting Leukemia Risk for AS Patients Treated With Now Banned 224Radium (SpondylAT)
AS patients who were treated with repeated intravenous injections of 224Radium (SpondylAT) are at increased risk for developing leukemia...
Autoimmunity: Cancer Drug Velcade Looks Promising for Lupus Nephritis
Bortezomib, which prolonged survival and prevented nephritis in mice with lupus, looks set to move to human clinical trials...
Consumer News: A List of Drugs That Increase Falling Risk
Many common prescription seizure medications, painkillers, and antidepressants may elevate the risk of falling among older patients...
BioPharm Business: Merck Serono Reports EMEA Confirms Positive Benefit-Risk Balance With Raptiva for the Treatment of Psoriasis; European Commission Approved Product Information Update to Include Data on Up to 3 Years of Treatment
The European Commission has approved an update of the Summary of Product Characteristics (SPC) for Raptiva (efalizumab) in the treatment of moderate-to-severe chronic plaque psoriasis...
|